Lenalidomide Generic Med

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on February 5, 2026.

Award Information

This solicitation resulted in an award to for approximately $899,347 on February 5, 2026. Similar contracts are typically issued by VETERANS AFFAIRS, DEPARTMENT OF under 325412 (Pharmaceutical Preparation Manufacturing).

Award Number
36F79720D0227
Award Amount
$899,347
Award Date
February 5, 2026

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in San Antonio, TX
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
36C25726N0241
Opportunity Type
Award Notice
Sub-Agency
VETERANS AFFAIRS, DEPARTMENT OF
Office
257-NETWORK CONTRACT OFFICE 17 (36C257)
Posted Date
Thursday, February 5, 2026
Response Deadline
Not specified
PSC Code
6505
Set-Aside
No Set Aside
Place of Performance
San Antonio, TX, 78240
Status
Active

Description

Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers. The purpose of this contract is to establish a reliable and continuous supply of lenalidomide primarily used to treat multiple myeloma, anemia in myelodysplastic syndromes, and certain types of lymphoma.

Why This Opportunity Matters

VETERANS AFFAIRS, DEPARTMENT OF is seeking responses for pharmaceutical preparation manufacturing with a set-aside for No Set Aside businesses in San Antonio, TX. This set-aside designation means eligible businesses face reduced competition from larger firms.